ENT Department, Pitié-Salpêtrière Hospital, AP-HP, Paris, France.
Sorbonne University, Paris, France.
Eur Arch Otorhinolaryngol. 2022 Feb;279(2):1091-1097. doi: 10.1007/s00405-021-07043-6. Epub 2021 Aug 17.
To evaluate functional results of facial nerve repair by direct nerve suture or grafting, compare results between a traumatic and a tumoral group and identify prognostic factors.
A retrospective monocentric cohort study was studied in a university ENT department. Thirty-one patients who benefited from facial nerve suture or grafting, with at least 12 months postoperative follow-up were included. Patients were divided into two groups according to the lesion type: traumatic (accident of the public road or iatrogenic) and tumoral. Preoperative data studied were sex, side, etiology documented by CT and/or MRI, facial palsy duration and grade according to House Brackmann grading system. Intraoperative data included: surgeon, age of patient, surgical technique, graft type, use of biological glue, facial nerve derivation, lesioned site. Postoperative data included: histological diagnosis, radiotherapy history, time to onset of the first signs of reinnervation, follow-up duration, and final facial function.
Success rate, including grade III and IV, was 68% in the whole cohort, 79% in the traumatic group and 59% in the tumoral group. Patients presenting with facial palsy evolving less than 6 months had better recovery results than those evolving longer than 6 months (p = 0.02). No other prognostic factors were identified.
The best outcome that can be achieved by suture or grafting of the facial nerve in traumatic or tumoral lesions is a grade III. Preoperative facial palsy duration is a prognostic factor and must be considered when establishing an operative indication.
评估直接神经缝合或移植修复面神经的功能结果,比较创伤性和肿瘤性组之间的结果,并确定预后因素。
本研究为单中心回顾性队列研究,在大学耳鼻喉科进行。共纳入 31 例接受面神经缝合或移植术且术后随访至少 12 个月的患者。根据病变类型将患者分为两组:创伤性(道路事故或医源性)和肿瘤性。研究的术前数据包括:性别、侧别、CT 和/或 MRI 记录的病因、面瘫持续时间和 House Brackmann 分级系统的分级。术中数据包括:手术医生、患者年龄、手术技术、移植物类型、生物胶使用、面神经引出、损伤部位。术后数据包括:组织学诊断、放疗史、首次出现再神经支配迹象的时间、随访时间和最终面部功能。
在整个队列中,成功率(包括 III 级和 IV 级)为 68%,创伤性组为 79%,肿瘤性组为 59%。面瘫持续时间小于 6 个月的患者比面瘫持续时间大于 6 个月的患者恢复效果更好(p=0.02)。未发现其他预后因素。
在创伤性或肿瘤性病变中,通过缝合或移植修复面神经,最好的结果是达到 III 级。术前面瘫持续时间是一个预后因素,在确定手术适应证时必须考虑到这一点。